- Home
- BGC vs GRFS Comparison
BGC vs GRFS Comparison
Compare BGC & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGC
- GRFS
- Stock Information
- Founded
- BGC 1945
- GRFS 1940
- Country
- BGC United States
- GRFS Spain
- Employees
- BGC N/A
- GRFS N/A
- Industry
- BGC Investment Bankers/Brokers/Service
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- BGC Finance
- GRFS Health Care
- Exchange
- BGC Nasdaq
- GRFS Nasdaq
- Market Cap
- BGC 4.7B
- GRFS 5.1B
- IPO Year
- BGC 1999
- GRFS 2006
- Fundamental
- Price
- BGC $9.18
- GRFS $7.27
- Analyst Decision
- BGC Strong Buy
- GRFS
- Analyst Count
- BGC 2
- GRFS 0
- Target Price
- BGC $14.00
- GRFS N/A
- AVG Volume (30 Days)
- BGC 2.9M
- GRFS 1.2M
- Earning Date
- BGC 04-29-2025
- GRFS 01-01-0001
- Dividend Yield
- BGC 0.87%
- GRFS N/A
- EPS Growth
- BGC 265.36
- GRFS 283.33
- EPS
- BGC 0.25
- GRFS 0.24
- Revenue
- BGC $2,171,743,000.00
- GRFS $7,467,006,939.00
- Revenue This Year
- BGC $13.55
- GRFS $8.45
- Revenue Next Year
- BGC $8.03
- GRFS $7.08
- P/E Ratio
- BGC $36.09
- GRFS $35.67
- Revenue Growth
- BGC 11.48
- GRFS 9.41
- 52 Week Low
- BGC $7.43
- GRFS $5.79
- 52 Week High
- BGC $11.79
- GRFS $9.96
- Technical
- Relative Strength Index (RSI)
- BGC 47.28
- GRFS 37.73
- Support Level
- BGC $8.40
- GRFS $7.13
- Resistance Level
- BGC $9.99
- GRFS $7.81
- Average True Range (ATR)
- BGC 0.30
- GRFS 0.24
- MACD
- BGC 0.05
- GRFS -0.11
- Stochastic Oscillator
- BGC 49.06
- GRFS 13.33
About BGC BGC Group Inc.
BGC Group Inc is a brokerage and financial technology company that serves the global financial markets, energy and commodities markets. Its service and product offerings include brokerage for a wide range of financial products including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically the company generates revenue from Asia, Other Europe/MEA, France, Other Americas with the majority of its revenue coming from United Kingdom followed by the United States.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.